Cargando…
Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature
BACKGROUND: Non-small cell lung cancer (NSCLC) represents more than about 80% of the lung cancer. The early stages of NSCLC can be treated with complete resection with a good prognosis. However, most cases are detected at late stage of the disease. The average survival rate of the patients with inva...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245590/ https://www.ncbi.nlm.nih.gov/pubmed/30453959 http://dx.doi.org/10.1186/s12920-018-0413-3 |